San Francisco, CA, United States of America

Rohith Srivas

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lexent Bio, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rohith Srivas: Innovator in Nucleic Acid Sequencing

Introduction

Rohith Srivas is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of nucleic acid sequencing, showcasing his innovative spirit and technical expertise. His work is particularly focused on enhancing the methods and systems used in sequencing technologies.

Latest Patents

Rohith holds a patent for "Multiple sequencing using a single flow cell." This patent outlines methods and systems for nucleic acid sequencing that utilize a single flow cell to perform both unbiased and biased sequencing. The invention aims to generate libraries of nucleic acid molecules efficiently. The method involves increasing the complexity of a sample for sequencing by pooling nucleic acid samples with varying degrees of complexity to achieve a desired level of complexity.

Career Highlights

Rohith is currently associated with Lexent Bio, Inc., where he applies his knowledge and skills to advance the field of biotechnology. His innovative approach has led to the development of cutting-edge sequencing technologies that have the potential to revolutionize genetic research and diagnostics.

Collaborations

Rohith has collaborated with notable colleagues, including Timothy Wilson and Haluk Tezcan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in the field.

Conclusion

Rohith Srivas is a key figure in the realm of nucleic acid sequencing, with a focus on improving sequencing methodologies. His contributions through patents and collaborations highlight his commitment to advancing biotechnology. His work continues to pave the way for future innovations in genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…